VetStem receives immunotherapy license from human health firmJuly 15, 2019Biopharmaceutical animal health company VetStem has partnered with Calidi Biotherapeutics, a clinical‐stage biotechnology company specializing in the stem cell-based delivery of oncolytic virus-based immunotherapies for cancer.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
VetStem celebrates business milestoneMay 23, 2016Ten veterinarians have combined to perform more than 1,000 stem cell procedures using the technology of VetStem Biopharma, the company reported Friday.